Evolution of Clinical Trial Imaging and Co-clinical Imaging-Reference-Cited by-同舟云学术

Evolution of Clinical Trial Imaging and Co-clinical Imaging

Published:2020 Issue: Volume: Page:239-253
ISSN:0942-5373
Container-title:Therapy Response Imaging in Oncology
language:
Short-container-title:

Author:

Lee Amy Junghyun,Suh Chong Hyun,Kim Kyung Won

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-030-31171-1_14

Reference44 articles.

1. Amur S, LaVange L, Zineh I, Buckman-Garner S, Woodcock J (2015) Biomarker qualification: toward a multiple stakeholder framework for biomarker development, regulatory acceptance, and utilization. Clin Pharmacol Ther 98(1):34–46

2. Bae H, Tsuchiya J, Okamoto T, Ito I, Sonehara Y, Nagahama F et al (2018) Standardization of [F-18]FDG PET/CT for response evaluation by the radiologic Society of North America-Quantitative Imaging Biomarker Alliance (RSNA-QIBA) profile: preliminary results from the Japan-QIBA (J-QIBA) activities for Asian international multicenter phase II trial. Jpn J Radiol 36(11):686–690

3. Beaumont H, Evans TL, Klifa C, Guermazi A, Hong SR, Chadjaa M et al (2018) Discrepancies of assessments in a RECIST 1.1 phase II clinical trial—association between adjudication rate and variability in images and tumors selection. Cancer Imaging 18(1):50

4. Biomarkers, Definitions, Working, Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89–95

5. Chamberlain M, Junck L, Brandsma D, Soffietti R, Ruda R, Raizer J et al (2017) Leptomeningeal metastases: a RANO proposal for response criteria. Neuro-Oncology 19(4):484–492

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uncover This Tech Term: Independent Central Image Reading;Korean Journal of Radiology;2023